Pharma

Your Article Summary

See Latest Articles

Fda advisory panel makes favorable recommendation for glaxosmithkline and genmab's arzerra (ofatumumab)
Genmab, 06/01/09

GlaxoSmithKline and Genmab A/S announced that the United States Food and Drug Administration's Oncologic Drugs Advisory Committee voted 10 to 3 that the ARZERRA data are reasonably likely to predict clinical benefit for patients with chronic lymphocytic leukemia whose disease is refractory to fludarabine and alemtuzumab. Ofatumumab is an investigational treatment.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

See All of Drug/Product Approvals